Genetic immunization of chimpanzees chronically infected with the hepatitis B virus, using a recombinant retroviral vector encoding the hepatitis B virus core antigen

Human Gene Therapy

Volumn 9, Issue 12, 1998, Pages 1719-1729

  Sällberg, Matti ^a,b   Hughes, Janice ^c   Javadian, Ali ^d   Ronlov, Greg ^a   Hultgren, Catharina ^b   Townsend, Kay ^a   Anderson, Carol Gay ^a   O'Dea, Joanne ^a   Alfonso, Jean ^a   Eason, Robert ^d   Murthy, Krishna K ^e   Jolly, Douglas J ^a   Chang, Stephen M ^a,f   Mento, Steven J ^a,g   Milich, David ^c   Lee, William T ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d Alamogordo Primate Facility   (United States)

^e SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^f MERCK RESEARCH LABORATORIES   (United States)

^g PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CD4 ANTIGEN; CD8 ANTIGEN; HEPATITIS B ANTIBODY; HYBRID PROTEIN; VIRUS ANTIGEN; VIRUS VECTOR;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CHIMPANZEE; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG SAFETY; GENE THERAPY; HEPATITIS B; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOSTIMULATION; IMMUNOTHERAPY; INTRAMUSCULAR DRUG ADMINISTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; SEROCONVERSION; VIRUS LOAD; VIRUS RECOMBINANT;

EID: 17344369213     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1998.9.12-1719     Document Type: Article

References (7)

1. BERTOLETTI, A., FERRARI, C., FIACCADORI, F., PENNA, A., MARGOLSKEE, R., SCHLICHT, H.J., FOWLER, P., GUILHOT, G., and CHISARI, F.V. (1991). HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen. Proc. Natl. Acad. Sci. U.S.A. 88, 10445-10449.
2. CARMEN, W.F., BONER, W., FATTOVICH, G., COLMAN, K., DORNAN, E.S., THURSZ, M., and HADZIYANNIS, S. (1997). Hepatitis B virus core protein mutations are concentrated in B cell epitopes in progressive disease and in T cell epitopes during clinical remission. J. Infect. Dis. 175, 1093-1100.
3. CHADA, S., DEJESUS, C.E., TOWNSEND, K., LEE, W.T., LAUBE, L., JOLLY, D.J., CHANG, S.M., and WARNER, J.F. (1993). Cross-reactive lysis of human targets infected with prototypic and clinical human immunodeficiency virus type 1 (HIV-1) strains by murine anti-HIV-1 HIB Env-specific cytotoxic T lymphocytes. J. Virol. 67, 3409-3417.
4. WARNER, J.F., ANDERSON, C.-G., LAUBE, L., JOLLY, D.J., TOWNSEND, K., CHADA, S., and ST. LOUIS, D. (1991). Induction of HIV-specific CTL and antibody responses in mice using retroviral vector-transduced cells. AIDS Res. Hum. Retroviruses 7, 645-655.
5. YUAN, T.T.-T., LIN, M.-H., QIU, S.M., and SHIH, C. (1998a). Functional characterization of naturally-occurring variants of human hepatitis B virus containing the core internal deletion mutation. J. Virol. 72, 2168-2176.
6. YUAN, T.T.-T., LIN, M.-H., CHEN, D.-S., and SHIH, C. (1998b). A defective interference-like phenomenon of human hepatitis B virus in chronic carriers. J. Virol. 72, 578-584.
7. Encoded antigens in acute and chronic hepatitis B virus infection. J. Immunol. 145, 3442-3449.